Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report

The most common variant of cutaneous T‐cell lymphomas (CTCL) is mycosis fungoides (MF). Patients with MF often experience a chronic course of disease. The spontaneous regression (SR) of MF is rare, and the factors that predict SR have not been recognized yet. Here, we are reporting a case of persist...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohadi, Laya, Hosseinzadeh, Fatemeh, Dadkhahfar, Sahar, Nasiri, Soheila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978791/
https://www.ncbi.nlm.nih.gov/pubmed/35387287
http://dx.doi.org/10.1002/ccr3.5682
_version_ 1784681031943585792
author Ohadi, Laya
Hosseinzadeh, Fatemeh
Dadkhahfar, Sahar
Nasiri, Soheila
author_facet Ohadi, Laya
Hosseinzadeh, Fatemeh
Dadkhahfar, Sahar
Nasiri, Soheila
author_sort Ohadi, Laya
collection PubMed
description The most common variant of cutaneous T‐cell lymphomas (CTCL) is mycosis fungoides (MF). Patients with MF often experience a chronic course of disease. The spontaneous regression (SR) of MF is rare, and the factors that predict SR have not been recognized yet. Here, we are reporting a case of persistent MF who had prominent remission after COVID‐19. This case report supports the possible antineoplastic effect of SARS‐CoV‐2. Understanding the underlying etiology of such effect can result in development of new target therapies for MF.
format Online
Article
Text
id pubmed-8978791
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89787912022-04-05 Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report Ohadi, Laya Hosseinzadeh, Fatemeh Dadkhahfar, Sahar Nasiri, Soheila Clin Case Rep Case Reports The most common variant of cutaneous T‐cell lymphomas (CTCL) is mycosis fungoides (MF). Patients with MF often experience a chronic course of disease. The spontaneous regression (SR) of MF is rare, and the factors that predict SR have not been recognized yet. Here, we are reporting a case of persistent MF who had prominent remission after COVID‐19. This case report supports the possible antineoplastic effect of SARS‐CoV‐2. Understanding the underlying etiology of such effect can result in development of new target therapies for MF. John Wiley and Sons Inc. 2022-04-04 /pmc/articles/PMC8978791/ /pubmed/35387287 http://dx.doi.org/10.1002/ccr3.5682 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Ohadi, Laya
Hosseinzadeh, Fatemeh
Dadkhahfar, Sahar
Nasiri, Soheila
Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report
title Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report
title_full Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report
title_fullStr Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report
title_full_unstemmed Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report
title_short Oncolytic effect of SARS‐CoV‐2 in a patient with mycosis fungoides: A case report
title_sort oncolytic effect of sars‐cov‐2 in a patient with mycosis fungoides: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978791/
https://www.ncbi.nlm.nih.gov/pubmed/35387287
http://dx.doi.org/10.1002/ccr3.5682
work_keys_str_mv AT ohadilaya oncolyticeffectofsarscov2inapatientwithmycosisfungoidesacasereport
AT hosseinzadehfatemeh oncolyticeffectofsarscov2inapatientwithmycosisfungoidesacasereport
AT dadkhahfarsahar oncolyticeffectofsarscov2inapatientwithmycosisfungoidesacasereport
AT nasirisoheila oncolyticeffectofsarscov2inapatientwithmycosisfungoidesacasereport

Ejemplares similares